Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05313685 · ClinicalTrials.gov registry record
Educational Materials for Hiccups
A clinical trial of Hiccup, sponsored by Mayo Clinic.
- Completed
- Registry status
- 50
- Enrollment target
- 1
- Study location
NCT05313685: Completed study of Hiccup, sponsored by Mayo Clinic.
NCT05313685 is a study of Hiccup that has completed, run by Mayo Clinic. The registered enrollment target is 50 participants. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05313685, a study of Hiccup, has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- 50 participants
- Enrollment target
- 1
- Study location
Study Summary
This is a research study about hiccup educational materials. The purpose of this study is to learn whether this type of research can be done.
Primary Outcome
This is a feasibility study that seeks to enroll 20 patients with hiccups in 5 months from the start of trial recruitment.
Conditions Studied
Study Locations (1)
Minnesota
- Mayo Clinic Rochester - Rochester
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2021-12-06 |
| Est. Completion | 2022-03-25 |
What the finished NCT05313685 record still lists
NCT05313685 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 50 participants, a relatively small participant target.
The record links to 1 condition, with Hiccup appearing as the primary indexed condition, and to 0 interventions.
NCT05313685 reports a single indexed study location in Minnesota.
Frequently Asked Questions
What is clinical trial NCT05313685 about?
NCT05313685 is a clinical study titled "Educational Materials for Hiccups". This is a research study about hiccup educational materials. The purpose of this study is to learn whether this type of research can be done.
What is the current status of trial NCT05313685?
This trial is currently completed. The enrollment target is 50 participants. The study started on 2021-12-06. Estimated completion is 2022-03-25.
What conditions does trial NCT05313685 study?
This clinical trial studies the following conditions: Hiccup.
Who is sponsoring clinical trial NCT05313685?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05313685 being conducted?
This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00200889 · 50 participants · Early Phase 1
Mapping Auricular Vagus Nerve Circuitry
- NCT00409435 · 50 participants · Phase 2
A Study of Pyridostigmine in Postural Tachycardia Syndrome
- NCT01202305 · 50 participants
The Use of Lymph Node Biopsies to Support HIV Pathogenesis Studies
- NCT01225913 · 50 participants · Phase 4
Mechanism(s) of Airflow Limitation During Exacerbation of Asthma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI